Sobre este episodio
A new study involving very young children in Mali and Burkina Faso suggests that a new vaccine combination developed by the UK-based pharma company GSK could reduce deaths and illness from malaria by 70% and millions of lives could be saved every year. We hear more from Dr Daniel Chandramohan, Professor of Public Health at the London School of Hygiene and Tropical Medicine; he co-authored the report on the trials. And as central bankers from around the world prepare to meet virtually to discuss challenging issues like inflation, we get the markets' reaction from Cary Leahey at Decision Economics.
